GLP-1s vs peptides vs drops vs shots…

There’s a lot of hype right now—but what does the science actually say?

We hosted a powerful discussion with a UC Berkeley biology graduate and a Harvard PhD, and the interest was so big we had to upgrade our Zoom room.

If you want to see the replay, comment REPLAY and I’ll drop the link below. 👇

3/10 Edited to

In recent years, GLP-1 receptor agonists have gained significant attention due to their role in managing type 2 diabetes and supporting weight loss. These medications work by mimicking the hormone GLP-1, which enhances insulin secretion and promotes a feeling of fullness. Beyond injections, the market is expanding with various forms such as peptides, oral drops, and other delivery methods. While injections have been the traditional route, many seek alternatives like oral peptides or drops to improve convenience and adherence. However, it's important to understand that the bioavailability and effectiveness can vary significantly between forms. From my experience and conversations with healthcare providers, peptides as supplements may offer some benefits but often lack the potent clinical backing found in prescription GLP-1 drugs. Drops marketed for appetite control or metabolism boost might contain ingredients with limited evidence, so it’s crucial to approach these with caution and consult a professional. Scientific discussions, such as those led by experts from esteemed institutions, provide clarity on these options by evaluating clinical trials, side effects, and long-term impact. For anyone considering GLP-1s or alternatives, educating oneself through credible sources and medical advice is key. Ultimately, the choice between GLP-1 injections, peptides, drops, or shots depends on individual health needs, physician guidance, and the latest research. Staying informed and engaging in expert dialogues, like the mentioned UC Berkeley and Harvard session, empowers better decisions in managing health effectively.